Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 68 (9), 1243-55

Vancomycin-induced Nephrotoxicity: Mechanism, Incidence, Risk Factors and Special Populations. A Literature Review

Affiliations
Review

Vancomycin-induced Nephrotoxicity: Mechanism, Incidence, Risk Factors and Special Populations. A Literature Review

Sepideh Elyasi et al. Eur J Clin Pharmacol.

Abstract

Purpose: Treatment failures following vancomycin therapy in patients with methicillin-resistant Staphylococcus aureus infections have led to the utilization of higher doses of this antibiotic to achieve the trough concentrations of 10-20 μg/mL recommended by the Infectious Diseases Society of America clinical practice guideline. However, many questions remain on the safety of such high doses of vancomycin, specifically their nephrotoxic effects. In this review, we have collected available evidence on the nephrotoxicity of vancomycin, particularly in terms of its mechanism, incidence, predisposing factors and special target populations.

Method: The data were collected by searching Scopus, PubMed, Medline, and Cochrane database systematic reviews. The key words used as search terms were "vancomycin", "nephrotoxicity", "renal failure", "renal damage", "risk factors", "infants", "children", "adult", "elderly" and "pregnancy". We have included all relevant animal and human studies up to the date of publication.

Results and conclusion: Vancomycin-induced renal toxicity was reported in 10-20 % and 30-40 % of patients following conventional and high doses of vancomycin therapy, respectively .The most probable mechanism for its nephrotoxicity can be at least partially attributable to an increased production of reactive oxygen species and oxidative stress. There are a number of different risk factors which could accelerate or potentiate the occurrence of vancomycin-induced nephrotoxicity, with the most documented risk factors being high trough vancomycin level (especially >20 mg/L) or doses (>4 g/day), concomitant treatment with nephrotoxic agents, prolonged therapy (even more than 7 days), and admittance to an intensive care unit (especially prolonged stay). It is necessary to carry out more studies, especially those focused on the association between nephrotoxicity and high trough levels of vancomycin.

Similar articles

See all similar articles

Cited by 65 PubMed Central articles

See all "Cited by" articles

References

    1. Chemotherapy. 2006;52(4):178-84 - PubMed
    1. Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):753-62 - PubMed
    1. Pharmacotherapy. 1995 Jan-Feb;15(1):85-91 - PubMed
    1. Crit Care. 2007;11(2):R31 - PubMed
    1. Toxicology. 2005 Nov 15;215(3):227-33 - PubMed

MeSH terms

LinkOut - more resources

Feedback